HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giovanni Davì Selected Research

Boutonneuse Fever (Mediterranean Spotted Fever)

2/2014Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infection.
4/2010Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation.
1/2009Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giovanni Davì Research Topics

Disease

19Inflammation (Inflammations)
11/2016 - 10/2002
11Cardiovascular Diseases (Cardiovascular Disease)
02/2018 - 11/2003
11Thrombosis (Thrombus)
03/2017 - 03/2004
10Type 2 Diabetes Mellitus (MODY)
11/2017 - 03/2004
8Atherosclerosis
02/2018 - 01/2006
8Diabetes Mellitus
11/2015 - 01/2009
8Obesity
02/2015 - 10/2002
7Hypercholesterolemia
01/2011 - 07/2002
6Insulin Resistance
11/2017 - 11/2003
6Myocardial Infarction
01/2016 - 06/2007
6Neoplasms (Cancer)
10/2014 - 01/2004
5Stroke (Strokes)
01/2018 - 01/2009
5Atrial Fibrillation
01/2018 - 10/2013
5Hypertension (High Blood Pressure)
11/2016 - 03/2008
4Weight Loss (Weight Reduction)
11/2017 - 10/2002
4Venous Thromboembolism
04/2017 - 05/2014
4Vascular Diseases (Vascular Disease)
11/2015 - 11/2007
4Hyperglycemia
07/2015 - 03/2003
3Body Weight (Weight, Body)
11/2017 - 10/2002
3Abdominal Obesity
11/2017 - 09/2005
3Infections
01/2016 - 01/2005
3Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2015 - 09/2005
3Boutonneuse Fever (Mediterranean Spotted Fever)
02/2014 - 01/2009
3Diabetic Angiopathies (Diabetic Angiopathy)
08/2007 - 07/2003
2Carotid Stenosis (Carotid Artery Stenosis)
02/2018 - 03/2005
2Renal Insufficiency (Renal Failure)
04/2017 - 11/2016
2Chronic Renal Insufficiency
11/2016 - 09/2016
2Acute Coronary Syndrome
07/2014 - 12/2012
2Coronary Disease (Coronary Heart Disease)
04/2013 - 04/2005
2Rheumatoid Arthritis
09/2010 - 01/2009
2Chronic Kidney Failure (Chronic Renal Failure)
10/2009 - 01/2009
2Hemophilia A (Haemophilia)
07/2008 - 12/2004
1Atherosclerotic Plaque (Atheroma)
02/2018
1Chronic Obstructive Pulmonary Disease (COPD)
01/2018
1Prediabetic State (Prediabetes)
11/2017
1Embolism (Embolus)
04/2017

Drug/Important Bio-Agent (IBA)

22ThromboxanesIBA
11/2016 - 07/2003
15CD40 Ligand (CD40L)IBA
01/2016 - 07/2002
11Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2016 - 08/2008
6Oxidants (Oxidizing Agents)IBA
02/2018 - 10/2002
6AntioxidantsIBA
02/2018 - 03/2004
611-dehydro-thromboxane B2IBA
11/2016 - 10/2002
6Receptor for Advanced Glycation End ProductsIBA
09/2015 - 08/2007
5Proteins (Proteins, Gene)FDA Link
11/2016 - 12/2013
5ThrombinFDA Link
09/2015 - 11/2003
5IsoprostanesIBA
12/2013 - 01/2005
5P-SelectinIBA
12/2013 - 03/2003
5C-Reactive ProteinIBA
03/2008 - 10/2002
4LipidsIBA
02/2018 - 03/2004
4Glucose (Dextrose)FDA LinkGeneric
11/2017 - 01/2005
4CytokinesIBA
01/2016 - 01/2004
4LigandsIBA
09/2015 - 11/2007
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2012 - 07/2002
3AnticoagulantsIBA
04/2017 - 11/2015
3Pharmaceutical PreparationsIBA
04/2017 - 01/2012
3N,N-dimethylarginine (asymmetric dimethylarginine)IBA
11/2016 - 03/2008
3oxidized low density lipoproteinIBA
11/2015 - 01/2006
3Biomarkers (Surrogate Marker)IBA
11/2015 - 12/2012
3LDL CholesterolIBA
09/2015 - 01/2006
3ChemokinesIBA
07/2015 - 01/2009
2Metformin (Glucophage)FDA LinkGeneric
11/2017 - 03/2008
2Insulin (Novolin)FDA Link
11/2016 - 01/2005
2AdipokinesIBA
11/2016 - 09/2015
2HomocysteineIBA
03/2016 - 09/2012
2Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
03/2016 - 09/2012
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2016 - 06/2007
2Antihypertensive Agents (Antihypertensives)IBA
01/2016 - 02/2008
2Advanced Glycation End ProductsIBA
11/2015 - 08/2007
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2015 - 01/2005
2CholesterolIBA
09/2015 - 10/2013
2AdiponectinIBA
09/2015 - 12/2006
2PlatinumIBA
10/2014 - 05/2014
2CreatinineIBA
05/2014 - 10/2002
2EnzymesIBA
02/2014 - 06/2007
2Vitamin EFDA LinkGeneric
10/2013 - 03/2004
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
12/2012 - 08/2012
2Thromboxane Receptors (Thromboxane Receptor)IBA
01/2012 - 06/2011
2Atorvastatin (Lipitor)FDA Link
01/2011 - 11/2007
2von Willebrand FactorIBA
03/2008 - 03/2003
2SelectinsIBA
03/2008 - 02/2008
28-epi-prostaglandin F2alphaIBA
11/2007 - 01/2005
2Interleukin-6 (Interleukin 6)IBA
06/2007 - 07/2003
2Factor VIIa (Activated Factor VII)IBA
12/2004 - 11/2003
2prothrombin fragment 1IBA
01/2004 - 11/2003
1Lipid PeroxidesIBA
02/2018
1BilirubinIBA
02/2018
1omega-Chloroacetophenone (Mace)IBA
01/2018
1Insulin-Like Growth Factor II (Somatomedin A)IBA
11/2017
1Glucagon-Like Peptide 1 (GLP 1)IBA
11/2017
1Insulin-Like Growth Factor I (IGF-1)IBA
11/2017
1LiraglutideFDA Link
11/2017
1Vitamin KFDA Link
03/2017
1GlucosidasesIBA
11/2016
1Rosiglitazone (Avandia)FDA Link
11/2016
1AcarboseFDA LinkGeneric
11/2016

Therapy/Procedure

7Therapeutics
11/2015 - 07/2002
3Secondary Prevention
04/2017 - 01/2012
2Drug Therapy (Chemotherapy)
10/2014 - 05/2014
1Endarterectomy (Thromboendarterectomy)
02/2018
1Glycemic Control
11/2017